Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.23
-1.27 (-4.98%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Damora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,461 | 37 | 6 | 20 | 29 | 77 | |
| Market Cap Growth | 49672.74% | 500.17% | -68.63% | -33.64% | -61.57% | -75.78% | |
| Enterprise Value | 1,204 | 31 | -14 | -24 | -46 | -50 | |
| Last Close Price | 24.23 | 23.01 | 4.65 | 18.00 | 28.75 | 75.75 | |
| PB Ratio | 6.08 | 0.15 | 0.39 | 0.60 | 0.48 | 0.65 | |
| P/TBV Ratio | - | - | 0.42 | 0.60 | 0.48 | 0.65 | |
| Debt / Equity Ratio | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.07 | -1.07 | -0.89 | -1.02 | -1.06 | -0.92 | |
| Net Debt / EBITDA Ratio | 7.05 | 7.05 | 0.84 | 0.91 | 1.07 | 2.08 | |
| Net Debt / FCF Ratio | 38.29 | 38.29 | 0.76 | 0.89 | 1.51 | 2.06 | |
| Quick Ratio | 12.88 | 12.88 | 12.58 | 5.98 | 5.55 | 22.55 | |
| Current Ratio | 12.98 | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 | |
| Return on Equity (ROE) | -163.80% | -163.80% | -89.03% | -81.52% | -68.86% | -36.61% | |
| Return on Assets (ROA) | -16.46% | -16.46% | -38.15% | -40.90% | -39.15% | -22.22% | |
| Return on Capital Employed (ROCE) | -15.20% | -15.20% | -106.00% | -112.50% | -98.60% | -44.40% | |
| Earnings Yield | -14.36% | -570.92% | -350.08% | -196.45% | -209.48% | -67.61% | |
| FCF Yield | -0.46% | -18.30% | -304.10% | -189.08% | -146.60% | -68.63% | |
| Buyback Yield / Dilution | -17.79% | -17.79% | -8.87% | -4.58% | -0.58% | -452.45% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.